Athanasia Sesse

Ms. Athanasia Sesse

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AZAthanasios Zikopoulos
Athanasios Zikopoulos
PKPeriklis Katopodis
Periklis Katopodis
MFMaria Filiponi
Maria Filiponi
AZAthanasios Zachariou
Athanasios Zachariou
ASAthanasia Sesse
Athanasia Sesse
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Assisted reproductive technologies (ART) and, in particular, intracytoplasmic sperm injection (ICSI) transformed the management of male infertility by making fertility possible in previously untreatable cases. However, the bypassing of natural selection mechanisms at fertilization is fraught with the danger of transmission of genetic and epigenetic abnormalities. Male infertility is now a multifactorial disorder with notable contributions from single-gene defects, chromosomal abnormalities, and Y-chromosome microdeletions. The recent advances in next-generation sequencing and sperm omics have identified mutations and copy-number variations in genes critical for spermatogenesis, flagellar structure, and endocrine regulation. Along with these findings, an increasing body of evidence suggests that ART procedures can lead to a disruption of epigenetic reprogramming during gametogenesis and early embryogenesis, resulting in imprinting disorders and altered patterns of gene expression in the offspring. This review synthesizes recent progress in the molecular underpinnings of genetic and epigenetic hazards of ART, with an emphasis on clinical significance for reproductive counselling and ethical considerations for future generations.

14 March 2025 in Metabolic Brain Disease
Verified
Journal Article
Open access
PDF file
ASAthanasia Sesse
Athanasia Sesse
PLParis Ladias
Paris Ladias
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
DCDimitrios Chatzistefanidis
Dimitrios Chatzistefanidis
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
SMSofia I. Markoula
Sofia I. Markoula
More than 600 different metabolic disorders can lead to a clinical picture, where seizures are a main neurological manifestation, either as the primary clinical finding or as a part of a more complex phenotype. For these metabolic disorders, the term “metabolic epilepsy” is commonly used. About one in six metabolic epilepsies is treatable, constituting a well-defined subset of metabolic disorders, which is amenable to treatment targeting the primary cause of the seizures and reducing or preventing associated complications. However, the majority of metabolic disorders currently lack effective treatment, making them a major challenge both in clinical practice and in research. Herein, we provide an overview of both treatable and non-treatable metabolic epilepsies and discuss our current understanding of these disorders. We also perform pathway analysis in order to compare the pathways in which the genes associated with treatable and non-treatable metabolic epilepsies take part. This approach may orientate the research to particular pathways and explore novel treatment algorithms.

20 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AZAthanasios Zikopoulos
Athanasios Zikopoulos
PKPeriklis Katopodis
Periklis Katopodis
MFMaria Filiponi
Maria Filiponi
AZAthanasios Zachariou
Athanasios Zachariou
ASAthanasia Sesse
Athanasia Sesse
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Assisted reproductive technologies (ART) and, in particular, intracytoplasmic sperm injection (ICSI) transformed the management of male infertility by making fertility possible in previously untreatable cases. However, the bypassing of natural selection mechanisms at fertilization is fraught with the danger of transmission of genetic and epigenetic abnormalities. Male infertility is now a multifactorial disorder with notable contributions from single-gene defects, chromosomal abnormalities, and Y-chromosome microdeletions. The recent advances in next-generation sequencing and sperm omics have identified mutations and copy-number variations in genes crit-ical for spermatogenesis, flagellar structure, and endocrine regulation. Along with these findings, an increasing body of evidence suggests that ART procedures can lead to a disruption of epigenetic reprogramming during gametogenesis and early embryo-genesis, resulting in imprinting disorders and altered patterns of gene expression in the offspring. This review synthesizes recent progress in the molecular underpinnings of genetic and epigenetic hazards of ART, with an emphasis on clinical significance for reproductive counselling and ethical considerations for future generations.

Verified
Journal Article
Open access
PDF file
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
ASAthanasia Sesse
Athanasia Sesse
IBIoanna Bouba
Ioanna Bouba
SKSpiros Konitsiotis
Spiros Konitsiotis
SMSofia I. Markoula
Sofia I. Markoula
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Exome sequencing (ES) is an essential part in clinical diagnosis of hereditary disorders. However, ES can reveal secondary findings (SFs) in medically actionable genes that are not related to the patient’s phenotype. In this study, we performed ES to 280 unrelated individuals of a Greek cohort and calculated the frequency of SFs in 81 ACMG SF v3.2 genes. Variants were classified using the standards and guidelines established by the American College of Medical Genetics and Genomics (ACMG). We identified 12 individuals (4.3%) who carried a pathogenic (P)/likely pathogenic (LP) variant in genes associated with dominant disorders. The variants were found in genes BRCA1, BRCA2, MSH6, LDLR, MYH7, and TTN. Notably, we discovered a P founder variant for the Greek population and one P variant with high prevalence in BRCA1 gene. Additionally, we observed a high prevalence of P/LP variants in the LDLR gene. In conclusion, this is the first study that calculates the prevalence of P/LP variants in the ACMG actionable gene list for SFs in Greece. The results of our study could serve as a guide for the national carrier screening program and may contribute to the precise treatment of certain human disorders.

28 May 2026 in Children
Verified
Journal Article
Open access
PDF file
AZAnna Zisi
Anna Zisi
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
ASAthanasia Sesse
Athanasia Sesse
CKChrysoula Kosmeri
Chrysoula Kosmeri
ASAnastasios Serbis
Anastasios Serbis
Ekaterini C. SiomouEkaterini C. Siomou
Ekaterini C. Siomou
Background: Congenital anomalies of the kidney and urinary tract (CAKUT) comprise a broad spectrum of malformations and constitute the leading cause of end-stage kidney disease (ESKD) in childhood. Despite extensive research, a monogenic cause is identified in only ~10% of cases, while variable penetrance and expressivity suggest a more complex disease mechanism. Epigenetic and environmental factors have also been implicated, further complicating efforts to elucidate the etiology of these anomalies. Methods: Whole exome sequencing (WES) was performed in 47 individuals with isolated, non-syndromic congenital renal parenchymal anomalies. Results: Variants in four genes (BBS1, PKHD1, XPNPEP3, and KCTD1) were identified, each of which has an established role in nephrogenesis and is implicated in syndromic disorders in which CAKUT can occur as part of the clinical spectrum. In addition, a variant in GREB1L was detected, a gene previously associated with CAKUT. The WES analysis identified candidate variants in 10.6% of patients, consistent with diagnostic yields reported in comparable CAKUT studies. The genes harboring variants are involved in key biological processes, including signaling pathways, ciliary function, and mitochondrial biology, supporting their relevance for further investigation. Conclusions: Our findings support WES as a valuable tool for identifying clinically relevant variants and expanding the genetic landscape of CAKUT.